Immunocore
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $97,964 | $93,881 | $84,052 | $80,248 |
Gross Profit | 96,924 | 93,050 | 83,722 | 79,800 |
EBITDA | -14,875 | 9,963 | -16,463 | 10,907 |
EBIT | -15,655 | 9,109 | -16,440 | 9,872 |
Net Income | -10,300 | 5,023 | -23,771 | 8,736 |
Net Change In Cash | 97,964 | 93,881 | 84,052 | 80,248 |
Free Cash Flow | 25,550 | 137 | -17,535 | 20,299 |
Cash | 487,933 | 476,845 | 455,731 | 537,767 |
Basic Shares | 50,294 | 51,949 | 49,991 | 52,808 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $310,202 | $249,428 | $143,737 | $26,978 |
Gross Profit | 307,471 | 248,391 | 143,283 | -47,151 |
EBITDA | -38,504 | -51,646 | -38,354 | -166,715 |
EBIT | -41,861 | -55,736 | -42,768 | -174,306 |
Net Income | -51,087 | -55,287 | -52,543 | -133,126 |
Net Change In Cash | 310,202 | 249,428 | 143,737 | 26,978 |
Free Cash Flow | 20,888 | -2,485 | -33,466 | -130,757 |
Cash | 455,731 | 442,626 | 332,539 | 237,886 |
Basic Shares | 49,991 | 48,888 | 45,714 | 43,862 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.20 |
2025-03-31 | -$0.49 |
2024-12-31 | -$0.37 |
